EXPLANATIONS FOR HIGH-RATES OF ERADICATION WITH TRIPLE THERAPY USING METRONIDAZOLE IN PATIENTS HARBORING METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAINS
Aa. Vanzwet et al., EXPLANATIONS FOR HIGH-RATES OF ERADICATION WITH TRIPLE THERAPY USING METRONIDAZOLE IN PATIENTS HARBORING METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAINS, Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 250-252
In 4 of 17 Helicobacter pylori strains obtained from antral biopsy sam
ples, the registered primary resistance (MIC, >32 mu g/ml) appeared to
be nonstable after prolonged microaerophilic incubation. In all resis
tant strains tested, susceptibility could be obtained when culture und
er normal microaerophilic conditions was preceded by a period of anaer
obic incubation. Both of these findings may explain the observed discr
epancy between the results of in vitro susceptibility tests and the er
adication obtained in vivo.